Skip to main content
SOPHSector not reported

SOPHiA Genetics SA (SOPH) Insider Trading

In the last 90 days, 10 SOPHiA Genetics SA (SOPH) insiders reported no open-market purchases and 33 sales totaling $2,256,255. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 13, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 13, 2026Zhenyu XuChief Scientific OfficerSale4,000$7.18$28,727
Oct 12, 2026Philippe MenuChief Medical OfficerSale5,000$7.26$36,303
Oct 12, 2026Jurgi CamblongExecutive ChairmanSale8,500$7.26$61,671
Oct 5, 2026Well Daan VanChief Legal OfficerSale6,168$8.12$50,100
Oct 5, 2026Manuela ValenteChief People OfficerSale4,240$8.13$34,487
Oct 5, 2026Abhimanyu VermaChief Technology OfficerSale5,284$8.12$42,929
Oct 5, 2026Kevin PuylaertChief Sales OfficerSale216$8.04$1,737
Oct 5, 2026George CardozaChief Financial OfficerSale1,592$8.10$12,897
Oct 5, 2026Philippe MenuChief Medical OfficerSale7,394$8.13$60,100
Oct 5, 2026Jurgi CamblongExecutive ChairmanSale40,172$8.13$326,526

Common questions

SOPH insider trading FAQ

Are SOPH insiders buying or selling?
Over the last 90 days, SOPH insiders were net sellers, reporting $0.00 of open-market purchases and $2,256,255 of sales.
When was the last SOPH insider purchase?
No open-market insider purchase of SOPHiA Genetics SA stock was reported in the last 90 days.
Where does SOPH insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that SOPHiA Genetics SA officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.